Epidemiology of myocardial infarction.
Myocardial infarction is a key component of the burden of cardiovascular disease. The assessment of the incidence and case fatality of myocardial infarction are important determinants of the decline in coronary disease mortality. The change in biomarkers used to diagnose myocardial infarction raises several methodologic, clinical, and public health challenges, which are discussed herein.
Roger
Véronique L
VL
Division of Cardiovascular Diseases, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. roger.veronique@mayo.edu
D015415:Biomarkers / Q000097:blood; D002309:Cardiology / Q000639:trends; D052279:Creatine Kinase, MB Form / Q000097:blood; D006306:Health Surveys; D006801:Humans; D015994:Incidence; D009203:Myocardial Infarction / Q000175:diagnosis / Q000453:epidemiology*; D012720:Severity of Illness Index; D014336:Troponin / Q000097:blood; D014481:United States / Q000453:epidemiology
D015415:Biomarkers; D014336:Troponin; D052279:Creatine Kinase, MB Form